Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials

@article{Witt2019KetamineFS,
  title={Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials},
  author={Katrina G. Witt and Jennifer Potts and Anna A M Hubers and Michael F. Grunebaum and James W. Murrough and Colleen K. Loo and Andrea Cipriani and Keith Hawton},
  journal={Australian \& New Zealand Journal of Psychiatry},
  year={2019},
  volume={54},
  pages={29 - 45}
}
  • K. Witt, J. Potts, K. Hawton
  • Published 15 November 2019
  • Psychology, Medicine
  • Australian & New Zealand Journal of Psychiatry
Objective: Ketamine may reduce suicidal ideation in treatment-resistant depression. But it is not known how quickly this occurs and how long it persists. We undertook a systematic review and meta-analysis to determine the short- and long-term effectiveness of ketamine for suicidality. Method: CENTRAL, EMBASE, Medline, and PsycINFO were searched until 12 December 2018. Randomised controlled trials of ketamine or esketamine reporting data on suicidal ideation, self-harm, attempted or completed… 

Figures from this paper

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
TLDR
Systematic reviews and meta-analyses provide support for robust, rapid and transient antidepressant and anti-suicidal effects of ketamine in treating mental health disorders.
Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review
TLDR
Preliminary mixed evidence suggests the possible utility of several pharmacological (ketamine, esketamine paroxetine, and buprenorphine) and non-pharmacological (a crisis response plan, and assertive case management) interventions.
Ketamine for Bipolar Depression: A Systematic Review
TLDR
Some preliminary evidence supporting use of intravenous racemic ketamine to treat adults with bipolar depression is found, with Ketamine was reasonably well tolerated; however, 2 participants developed manic symptoms.
Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses.
TLDR
Ketamine and esketamine showed a significant antidepressant action within a few hours or days after administration; however, the long-term efficacy and safety are lacking.
Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences
TLDR
Ketamine treatment was generally experienced as effective in improving mood and reducing suicidal ideation in the short term, but the lack of longer-term benefit was challenging for participants, as was treatment cost.
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk
TLDR
The history and the current understanding of the role of ketamine and esketamine in depression and suicidal ideation and behavior are discussed and a consistent picture of benefits that appears to outweigh the potential risks of the treatment is drawn.
Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys
TLDR
Subgroup and meta-regression analyses revealed that source of patients, survey countries, and sample size were significantly associated with the point prevalence of SI, while male proportion and quality assessment scores were significantly related with the lifetime and point prevalence.
Ketamine treatment for depression: a review
This manuscript reviews the clinical evidence regarding single-dose intravenous (IV) administration of the novel glutamatergic modulator racemic (R,S)-ketamine (hereafter referred to as ketamine) as
...
...

References

SHOWING 1-10 OF 60 REFERENCES
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
TLDR
Consistent with clinical research on ketamine as a rapid and effective treatment for depression, ketamine has shown early preliminary evidence of a reduction in depressive symptoms, as well as reducing SI, with minimal short-term side effects.
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
TLDR
Ketamine rapidly reduced suicidal thoughts, within 1 day and for up to 1 week in depressed patients with suicidal ideation, although subsequent trials in transdiagnostic samples are required to confirm that ketamine exerts a specific effect on suicidal Ideation.
Ketamine administration in depressive disorders: a systematic review and meta-analysis
TLDR
The present meta-analysis confirms ketamine’s efficacy in depressive disorders in non-ECT studies, as well as in ECT studies, and further studies are warranted to detail efficacy in bipolar disorders and other specific depressed populations.
Suicidal ideation and subsequent completed suicide in both psychiatric and non-psychiatric populations: a meta-analysis
TLDR
This meta-analysis of cohort and case–control studies that assessed suicidal ideation as determinant for completed suicide in adults found that expression of suicidal Ideation in psychiatric patients should prompt secondary prevention strategies to reduce their substantial increased risk of suicide.
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
TLDR
Suicidal ideation in the context of MDD improved within 40 minutes of a ketamine infusion and remained improved for up to 4 hours postinfusion.
Treatment-resistant depression and suicidality.
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
TLDR
Low-dose ketamine appears more effective than very low dose, but there is substantial heterogeneity in clinical response, with remission among one-fifth of patients at 1 week but most others having benefits that are less durable.
Psychosocial interventions following self-harm in adults: a systematic review and meta-analysis.
...
...